Patents by Inventor David McGaw

David McGaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100221746
    Abstract: The present invention relates to pharmaceutical compositions for the treatment and/or prophylaxis of disease associated with fibrosis in a vertebrate, said composition comprising at least one activin antagonist, and optionally a pharmaceutically acceptable carrier, adjuvant and/or diluent. The invention also relates to methods of treatment of disease associated with fibrosis in a vertebrate, as well as methods for diagnosing such conditions, and kits therefor.
    Type: Application
    Filed: May 17, 2010
    Publication date: September 2, 2010
    Applicants: Inhibin Pty Limited, Monash University
    Inventors: David Phillips, David de Kretser, William Sievert, Shane Patella, Joseph Smolich, David McGaw, Paul Fennessy
  • Publication number: 20090226460
    Abstract: The present invention relates to pharmaceutical compositions for the treatment and/or prophylaxis of disease associated with fibrosis in a vertebrate, said composition comprising at least one activin antagonist, and optionally a pharmaceutically acceptable carrier, adjuvant and/or diluent. The invention also relates to methods of treatment of disease associated with fibrosis in a vertebrate, as well as methods for diagnosing such conditions, and kits therefor.
    Type: Application
    Filed: March 6, 2009
    Publication date: September 10, 2009
    Applicants: Inhibin Pty Limited, Monash Univeristy
    Inventors: David Phillips, David de Kretser, William Sievert, Shane Patella, Joseph Smolich, David McGaw, Paul Fennessy
  • Publication number: 20040209805
    Abstract: The present invention relates to pharmaceutical compositions for the treatment and/or prophylaxis of disease associated with fibrosis in a vertebrate, said composition comprising at least one activin antagonist, and optionally a pharmaceutically acceptable carrier, adjuvant and/or diluent. The invention also relates to methods of treatment of disease associated with fibrosis in a vertebrate, as well as methods for diagnosing such conditions, and kits therefor.
    Type: Application
    Filed: January 12, 2004
    Publication date: October 21, 2004
    Applicants: BIOA Pty Limited, Monash University
    Inventors: David Phillips, David de Kretser, William Sievert, Shane Patella, Joseph Smolich, David McGaw, Paul Fennessy